Join to View Full Profile
155 E 38th StApt 3LNew York, NY 10016
Phone+1 212-986-6693
Fax+1 212-202-4305
Dr. Brodie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Psychiatry, 1975 - 1978- New York University School of MedicineClass of 1975
U.of WisconsinPhD, Physiological Chemistry, 1958 - 1962
Certifications & Licensure
NY State Medical License 1976 - 2026
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Castle & Connoly Metropolitan New York, 2007-2023
- New York Magazine: Top Doctors Castle Connolly, 2002, 2009
- Super Doctor SuperDoctors.com
Clinical Trials
- Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence Start of enrollment: 2007 Apr 01
- Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder Start of enrollment: 2012 Jul 01
Publications & Presentations
PubMed
- 18 citationsSex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and ReplacementGiovanni C Santoro, Joseph Carrion, Krishna Patel, Crystal Vilchez, Jennifer Veith
Neuropsychopharmacology. 2017-04-10 - 1 citationsA Novel Strategy for Attenuating Opioid Withdrawal in Neonates.Giovanni C Santoro, Samarth Shukla, Krishna Patel, Jakub Kaczmarzyk, Stergiani Agorastos
Journal of Addiction Research & Therapy. 2016-08-11 - 40 citations(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.Yue Pan, Madina R. Gerasimov, Trine Kvist, Petrine Wellendorph, Karsten K. Madsen
Journal of Medicinal Chemistry. 2012-01-12
Press Mentions
Proposed Addiction Treatment Successful, Safe in Second Small TrialDecember 7th, 2004
It Isn’t That ShockingMay 7th, 2003
Grant Support
- PET And Schizophrenia--Cerebral Responses To Neuroleptic Schizo SubjectsNational Center For Research Resources1996–2002
- PET And Schizophrenia--Cerebral Response To NeurolepticsNational Institute Of Mental Health1996–1997
- PET And Schizophrenia--Cerebral Responses To Neuroleptic Schizo SubjectsNational Center For Research Resources1995–1996
- PET And Schizophrenia--Cerebral Response To NeurolepticsNational Institute Of Mental Health1995
- PET And Schizophrenia--Cerebral Responses To NeurolepticsNational Center For Research Resources1992–1994
- PET &Schizophrenia: Cerebral Response To NeurolepticsNational Institute Of Mental Health1992
- PET &Schizophrenia: Cerebral Response To NeurolepticsNational Institute Of Mental Health1991
- PET Studies In SchizophreniaNational Institute Of Mental Health1987–1989
- Core Facilities--New York UniversityNational Institute Of Neurological Disorders And Stroke1985
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
